| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |